HuGE Literature Finder
Records
1
-
8
Worldwide prevalence of PI3K-AKT-mTOR pathway mutations in head and neck cancer: A systematic review and meta-analysis. Critical reviews in oncology/hematology 2021 Mar 160 103284. Moura Adriana Castelo de, Assad Daniele Xavier, Amorim Dos Santos Juliana, Porto de Toledo Isabela, Barra Gustavo Barcelos, Castilho Rogerio Moraes, Squarize Cristiane Helena, Guerra Eliete Neves Sil |
Associations of genetic polymorphisms in pTEN/AKT/mTOR signaling pathway genes with cancer risk: A meta-analysis in Asian population. Scientific reports 2017 Dec 7 (1): 17844. Zhang Zhen, Chen Qiuchen, Zhang Jing, Wang Yilin, Hu Xiaoyun, Yin Sainan, He Miao, Guan Shu, Qin Wenyan, Xiao Qinghuan, Zhao Haishan, Yao Weifan, Wu Huizhe, Wei Minj |
Genetic polymorphisms of mTOR and cancer risk: a systematic review and updated meta-analysis. Oncotarget 2016 Jul . Zining Jin, Lu Xu, Caiyun He, Yuan Yu |
A Common Variant at the 14q32 Endometrial Cancer Risk Locus Activates AKT1 through YY1 Binding. American journal of human genetics 2016 Jun 98 (6): 1159-69. Painter Jodie N, Kaufmann Susanne, O'Mara Tracy A, Hillman Kristine M, Sivakumaran Haran, Darabi Hatef, Cheng Timothy H T, Pearson John, Kazakoff Stephen, Waddell Nicola, Hoivik Erling A, Goode Ellen L, Scott Rodney J, Tomlinson Ian, Dunning Alison M, Easton Douglas F, French Juliet D, Salvesen Helga B, Pollock Pamela M, Thompson Deborah J, Spurdle Amanda B, Edwards Stacey |
Associations of PI3KR1 and mTOR polymorphisms with esophageal squamous cell carcinoma risk and gene-environment interactions in Eastern Chinese populations. Scientific reports 2015 5 8250. Zhu Jinhong, Wang Mengyun, Zhu Meiling, He Jin, Wang Jiu-Cun, Jin Li, Wang Xiao-Feng, Xiang Jia-Qing, Wei Qing |
The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis. Acta oncologica (Stockholm, Sweden) 2014 Jul 53 (7): 852-64. Therkildsen Christina, Bergmann Troels K, Henrichsen-Schnack Tine, Ladelund Steen, Nilbert M |
Association of mTOR polymorphisms with cancer risk and clinical outcomes: a meta-analysis. PloS one 2014 9 (5): e97085. Shao Jianbo, Li Ying, Zhao Peiwei, Yue Xin, Jiang Jun, Liang Xiaohui, He Xueli |
Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC). PloS one 2011 6 (2): e16914. Campa Daniele, Hüsing Anika, Stein Angelika, Dostal Lucie, Boeing Heiner, Pischon Tobias, Tjønneland Anne, Roswall Nina, Overvad Kim, Østergaard Jane Nautrup, Rodríguez Laudina, Sala Núria, Sánchez Maria-José, Larrañaga Nerea, Huerta José María, Barricarte Aurelio, Khaw Kay-Tee, Wareham Nicholas, Travis Ruth C, Allen Naomi E, Lagiou Pagona, Trichopoulou Antonia, Trichopoulos Dimitrios, Palli Domenico, Sieri Sabina, Tumino Rosario, Sacerdote Carlotta, van Kranen Henk, Bueno-de-Mesquita H Bas, Hallmans Göran, Johansson Mattias, Romieu Isabelle, Jenab Mazda, Cox David G, Siddiq Afshan, Riboli Elio, Canzian Federico, Kaaks Rudo |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 07, 2023
- Content source: